Cardiovascular/Stroke Risk Stratification in Diabetic Foot Infection Patients Using Deep Learning-Based Artificial Intelligence: An Investigative Study.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Khanna Narendra N, Maindarkar Mahesh A, Viswanathan Vijay, Puvvula Anudeep, Paul Sudip, Bhagawati Mrinalini, Ahluwalia Puneet, Ruzsa Zoltan, Sharma Aditya, Kolluri Raghu, Krishnan Padukone R, Singh Inder M, Laird John R, Fatemi Mostafa, Alizad Azra, Dhanjil Surinder K, Saba Luca, Balestrieri Antonella, Faa Gavino, Paraskevas Kosmas I, Misra Durga Prasanna, Agarwal Vikas, Sharma Aman, Teji Jagjit S, Al-Maini Mustafa, Nicolaides Andrew, Rathore Vijay, Naidu Subbaram, Liblik Kiera, Johri Amer M, Turk Monika, Sobel David W, Miner Martin, Viskovic Klaudija, Tsoulfas George, Protogerou Athanasios D, Mavrogeni Sophie, Kitas George D, Fouda Mostafa M, Kalra Mannudeep K, Suri Jasjit S
Аннотация
A diabetic foot infection (DFI) is among the most serious, incurable, and costly to treat conditions. The presence of a DFI renders machine learning (ML) systems extremely nonlinear, posing difficulties in CVD/stroke risk stratification. In addition, there is a limited number of well-explained ML paradigms due to comorbidity, sample size limits, and weak scientific and clinical validation methodologies. Deep neural networks (DNN) are potent machines for learning that generalize nonlinear situations. The objective of this article is to propose a novel investigation of deep learning (DL) solutions for predicting CVD/stroke risk in DFI patients. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) search strategy was used for the selection of 207 studies. We hypothesize that a DFI is responsible for increased morbidity and mortality due to the worsening of atherosclerotic disease and affecting coronary artery disease (CAD). Since surrogate biomarkers for CAD, such as carotid artery disease, can be used for monitoring CVD, we can thus use a DL-based model, namely, Long Short-Term Memory (LSTM) and Recurrent Neural Networks (RNN) for CVD/stroke risk prediction in DFI patients, which combines covariates such as office and laboratory-based biomarkers, carotid ultrasound image phenotype (CUSIP) lesions, along with the DFI severity. We confirmed the viability of CVD/stroke risk stratification in the DFI patients. Strong designs were found in the research of the DL architectures for CVD/stroke risk stratification. Finally, we analyzed the AI bias and proposed strategies for the early diagnosis of CVD/stroke in DFI patients. Since DFI patients have an aggressive atherosclerotic disease, leading to prominent CVD/stroke risk, we, therefore, conclude that the DL paradigm is very effective for predicting the risk of CVD/stroke in DFI patients.